🇺🇸 menotropin in United States

22 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Ovarian Hyperstimulation Syndrome — 6 reports (27.27%)
  2. Off Label Use — 4 reports (18.18%)
  3. Abortion Spontaneous — 2 reports (9.09%)
  4. Cerebral Thrombosis — 2 reports (9.09%)
  5. Choroidal Neovascularisation — 2 reports (9.09%)
  6. Libido Decreased — 2 reports (9.09%)
  7. Adnexal Torsion — 1 report (4.55%)
  8. Adrenocorticotropic Hormone Deficiency — 1 report (4.55%)
  9. Appendicitis Perforated — 1 report (4.55%)
  10. Ascites — 1 report (4.55%)

Source database →

Other Other approved in United States

Frequently asked questions

Is menotropin approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for menotropin in United States?

Main Line Fertility Center is the originator. The local marketing authorisation holder may differ — check the official source linked above.